Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.
about
High-Resolution Microfluidic Single-Cell Transcriptional Profiling Reveals Clinically Relevant Subtypes among Human Stem Cell Populations Commonly Utilized in Cell-Based TherapiesBMPR2 spruces up the endothelium in pulmonary hypertensionPotential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in ratsEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.The cancer theory of pulmonary arterial hypertension.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertensionMicrofluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies.Transcriptional profiling and dynamical regulation analysis identify potential kernel target genes of SCYL1-BP1 in HEK293T cells.Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells.BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertensionElafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.Update in Pulmonary Vascular Diseases 2014.Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target SlugEvaluating the Effect of Cell Culture on Gene Expression in Primary Tissue Samples Using Microfluidic-Based Single Cell Transcriptional Analysis.TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertensionTranslational control mechanisms in angiogenesis and vascular biology.Regulators and effectors of bone morphogenetic protein signalling in the cardiovascular system.Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma.Prostaglandin E1 Attenuates Pulmonary Artery Remodeling by Activating Phosphorylation of CREB and the PTEN Signaling Pathway.Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques.Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.Beneficial effects of bile acid receptor agonists in pulmonary disease models.Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.Do BRD(4)S of a Feather Flock Together? How an Inflammation-Driven Epigenetic Regulator May Link Pulmonary Hypertension and Coronary Artery Disease.Macrophage Regulation during Vascular Remodeling: Implications for Pulmonary Hypertension Therapy.Macitentan reverses early obstructive pulmonary vasculopathy in rats: early intervention in overcoming the survivin-mediated resistance to apoptosis.[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertensionMacrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
P2860
Q26752337-6541A8A8-139B-40D0-97D2-E0D18A6DDB57Q26786834-26805804-6B9E-4375-A51A-765F4AE87E8BQ27313498-908AD41C-E86F-41A3-9487-1516B42DE0F0Q33608219-1F74C119-4E98-4E3B-B548-5F2DABF7C9E3Q33788493-6A45C4C7-90AD-4363-914B-87F2DFB3875CQ33898213-882697DA-8A45-43B0-B973-7E41A478A9C3Q33908347-C343CF7F-2916-40C4-BAE9-55C09205B71CQ34263334-7624C3C1-7C80-4578-B1BC-6B65DC9FAC5DQ34552442-72F72585-6DEC-4E68-B72E-36540CD423ECQ35376926-76C4C4A4-4101-4AAB-B96D-3905A10C3096Q35766693-9F34CD9D-347E-4FE2-87A7-6CC6A033F415Q36096312-61B4D956-2EFF-4EA7-B68C-205A03B3A83EQ36128639-6F602E73-CB2B-4059-9675-3E28C98D1407Q36480359-8779BD16-D5BC-45E5-91D7-F27957CF2F79Q36869381-504909C1-5773-40A0-80C9-8BA7BA391130Q37200833-9DAEF408-24CB-4AC6-BE98-AEA13114CDFFQ37591432-1ADBF61D-8AAF-4200-B059-661C212556C2Q37599544-F2BB342B-3F5A-4E0F-981F-34FD6867C59EQ38383020-4D01EFFD-0EF5-4205-9554-DACBB752248CQ38465654-4891E1EB-27C3-4134-B6B4-1CC295530458Q38601788-9AF27A33-1A02-40D5-8A6C-A14462B4866EQ38732718-57CEF2DC-D585-4AC2-A819-617BC4B43BF8Q38779774-BD2411B1-E500-48CA-918A-5EB63B66ED6CQ38893163-9A883BA9-6096-4F4E-96DB-32FA9AF7DA03Q41564326-10AF132C-3081-41FD-9702-1F41DE43C848Q41932506-0B947790-FAAE-44F6-94D4-807D1C7A7CBEQ45046014-73C776B4-7A8F-4A30-A1AB-F18D7D61B86EQ47277266-DA180BC1-DCA7-4B14-A539-697945C33131Q47449827-625F93E9-B837-40DE-88A9-FBA86842A07AQ47671148-2B1A859E-D31C-48A2-87F5-1B1C5796E879Q47741857-F7FCBAA6-0478-4AE1-9907-E6E331A82419Q52685710-3D46AB2B-A933-4D6A-8A45-90960EFA574DQ52720539-2F86F423-156A-4443-892C-FC961DB94799Q52761036-9A00D063-3183-46B2-B01A-9EFD4FD97EA8Q52874552-D6B5E22C-8573-42B2-9566-CB7B9072858EQ53659389-36DD04D6-1F34-49B1-9783-145BA4115B0CQ53767909-564444F9-A905-4412-BFC3-A96F4D63849BQ55008475-48470F8F-1D3C-4356-8F0B-CB704E4F7E49Q58273930-2EA6288A-54C5-4A05-A4F1-C3F37E6CE0CDQ58700113-25FA3841-395B-4E59-B913-8853A084D6EE
P2860
Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@en
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@nl
type
label
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@en
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@nl
prefLabel
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@en
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@nl
P2093
P2860
P50
P356
P1476
Reduced BMPR2 expression induc ...... erbate pulmonary hypertension.
@en
P2093
Edda Spiekerkoetter
Geoffrey C Gurtner
Leila Haghighat
Lingli Wang
Marlene Rabinovitch
Michael Januszyk
Nils P Nickel
Peter Sarnow
Pin-I Chen
P2860
P304
P356
10.1084/JEM.20111741
P407
P577
2014-01-20T00:00:00Z